Evidence map›Paper›PMID 34380438›Full record

ArticleBMC molecular and cell biology2021

SH3BGRL3 binds to myosin 1c in a calcium dependent manner and modulates migration in the MDA-MB-231 cell line.

Filippo Di Pisa, Elisa Pesenti, Maria Bono, Andrea N Mazzarello, Cinzia Bernardi, Michael P Lisanti, Giovanni Renzone, Andrea Scaloni, Ermanno Ciccone, Franco Fais and 3 more

Open access · goldAbstract read
In one paragraph

Article in BMC molecular and cell biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Pareto optimality reveals an atlas of cellular archetypes.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 3 countries.

Filippo Di Pisa *Department of Experimental Medicine, University of Genoa, 16132, Genoa, Italy.
Elisa Pesenti *Department of Experimental Medicine, University of Genoa, 16132, Genoa, Italy.
Maria BonoDepartment of Experimental Medicine, University of Genoa, 16132, Genoa, Italy.
Andrea N MazzarelloKarches Center for Oncology Research, The Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY, 11030, USA.
Cinzia BernardiMolecular Pathology Unit, IRCCS Policlinico San Martino, 16132, Genoa, Italy.
Michael P LisantiTranslational Medicine, School of Science, Engineering and Environment (SEE), University of Salford, Greater Manchester, UK.
Giovanni RenzoneProteomics and Mass Spectrometry Laboratory, ISPAAM-National Research Council, 80147, Naples, Italy.
Andrea ScaloniProteomics and Mass Spectrometry Laboratory, ISPAAM-National Research Council, 80147, Naples, Italy.
Ermanno CicconeDepartment of Experimental Medicine, University of Genoa, 16132, Genoa, Italy.
Franco FaisDepartment of Experimental Medicine, University of Genoa, 16132, Genoa, Italy.
Silvia BrunoDepartment of Experimental Medicine, University of Genoa, 16132, Genoa, Italy.
Paolo ScartezziniEnte Ospedaliero Ospedali Galliera, 16128, Genoa, Italy.
Fabio GhiottoDepartment of Experimental Medicine, University of Genoa, 16132, Genoa, Italy. fghiotto@unige.it.
University of Genoa · ITOspedale Policlinico San Martino · ITUniversity of Salford · GBEnte Ospedaliero Ospedali Galliera · ITFeinstein Institute for Medical Research · USIstituto per il Sistema Produzione Animale in Ambiente Mediterraneo · ITNational Research Council · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe human SH3 domain Binding Glutamic acid Rich Like 3 (SH3BGRL3) gene is highly conserved in phylogeny and widely expressed in human tissues. However, its function is largely undetermined. The protein was found to be overexpressed in several tumors, and recent work suggested a possible relationship with EGFR family members. We aimed at further highlighting on these issues and investigated SH3BGRL3 molecular interactions and its role in cellular migration ability.

resultsWe first engineered the ErbB2-overexpressing SKBR3 cells to express exogenous SH3BGRL3, as well as wild type Myo1c or different deletion mutants. Confocal microscopy analysis indicated that SH3BGRL3 co-localized with Myo1c and ErbB2 at plasma membranes. However, co-immunoprecipitation assays and mass spectrometry demonstrated that SH3BGRL3 did not directly bind ErbB2, but specifically recognized Myo1c, on its IQ-bearing neck region. Importantly, the interaction with Myo1c was Ca

conclusionThe results of this study provide insights for the formulation of novel hypotheses on the putative role of SH3BGRL3 protein in the regulation of myosin-cytoskeleton dialog and in cell migration. It could be envisaged the SH3BGRL3-Myo1c interaction as a regulation mechanism for cytoskeleton dynamics. It is well known that, at low Ca

Indexed as

Adaptor Proteins, Signal TransducingCalciumCalmodulinCell Line, TumorCell MembraneCell MovementCytoskeletal ProteinsHumansMyosin Type IProtein BindingAdaptor Proteins, Signal TransducingCalciumCalmodulinCytoskeletal ProteinsMYO1C protein, humanMyosin Type ISH3BGRL3 protein, humanCell migrationIQ domainMyosin 1cSH3BGRL3

Identifiers

PMID34380438
PMCPMC8356473
OpenAlexW3191194658

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.